UCI is a public medical care facility in partnership with the Ministry Of Health. Our main focus is on research, training, consultation, prevention and cancer treatment in areas of Pediatrics, Oncology, Gynecology, Radiotherapy, surgery, pharmacy and recently venturing into bone marrow transplants.
Our patients also receive palliative care and rehabilitation services. UCI maintains an in patients facility with a capacity of 80 beds and attends to an average of about 200 patients daily. We are located along upper Mulago hill road on Mulago hill, Central division Kampala about 5 Km North East of the central business district of the city.
UCI is affiliated with the Makerere University School of medicine and with the Mulago hospital complex; the teaching hospital for the medical school.
The Uganda Cancer Institute started with the initiation and development of the Lymphoma Treatment Centre (LTC) which was a result of corporation and hard work of many individuals at the Makerere University medical school, Ministry of Health (MOH) and the National cancer institute (NCI) in the USA.
Solid Tumor Centre opens its doors
The success of the Lymphoma treatment center lead to the foundation of a sister unit the Solid Tumor Centre (STC) in 1969 to enable additional investigations in adult cancers especially hepatocellular carcinoma, Kaposi's sarcoma and malignant melanoma to be carried out. Functioning jointly, the two units STC and LTC together with the associated laboratories formed the Uganda Cancer Institute (UCI).
Research progress over the years
1969 - 2014
The first report of the efficacy of chemotherapy alone in childhood Hodgkin’s disease came from the Institute, at a time when radiotherapy was the main modality in resource-rich countries for management of earlystage disease. A comprehensive description of adult and childhood endemic Kaposi’s sarcoma, response to treatment and early observation of an epidemic form of the disease in Africa came out of the Institute. The initial attempt at objective staging of hepatocellular carcinoma was the Kampala Staging Scheme, which was devised at the Institute and presented at the international symposium on liver cancer held in Kampala in 1971.
This was to be followed by the landmark report on the efficacy of adriamycin as a single agent in hepatocellular carcinoma. Given the challenge of the availability of chemotherapy in developing countries noted at the onset, the Institute proposed the concept of an essential drug list for cancer therapy which has since been accepted and adopted by the WHO as a key component of the global cancer control effort.
East Africa Center of excellence for oncology y
3rd October 2014
On 3rd October 2014, African Development Bank together with the Ugandan government sign an agreement to finance the establishment of Uganda Cancer Institute as the East African Center of excellence for oncology providing leadership in Cancer related trainings and services in the East African region.
UCI and Fred Hutchinson Cancer Research Center (Fred Hutch)-2015
The Fred Hutchinson Cancer Center in Seattle, Washington, U.S. and the Uganda Cancer Institute constructed a state-of-the-art facility that houses clinical outpatient care, five research laboratories, and a training center. The facility was funded in part by the U.S. Agency for International Development, investment by Fred Hutchinson Cancer Center, and the support of the Government of Uganda. The UCI-Fred Hutch Collaboration is a partnership between the UCI and Fred Hutchinson Cancer Center to conduct cancer and infectious disease research and to support capacity building for research and clinical care at the UCI and in Uganda.
The UCI-Fred Hutch Cancer Centre is a three-story, 16,700 square-foot facility that opened in May 2015, and features biomedical laboratories and spaces for training and outpatient care. It also houses a research biorepository, with over 150,000 biospecimens. A community cancer clinic is also developed in a rural district of Mayuge; it serves as pilot project in understanding cancer burden in a rural population.
UCI ACT 2016
The Uganda Cancer Institute act is passed by parliament giving it a legal basis to effectively deliver on its expanded mandate under the act of offering national leadership in cancer related activities.